 | • レポートコード：B-GIR08C0293 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アンロチニブの世界市場について調べ、まとめました。種類別セグメントは、8mgカプセル、10mgカプセル、12mgカプセル等、用途別セグメントは、NPO、政府、個人用、その他等に区分しました。アンロチニブの世界市場概観、企業動向、企業別アンロチニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アンロチニブの市場概観 ・アンロチニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アンロチニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・アンロチニブの世界市場規模 ・アンロチニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・アンロチニブのアメリカ市場規模推移 ・アンロチニブのカナダ市場規模推移 ・アンロチニブのメキシコ市場規模推移 ・アンロチニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・アンロチニブのドイツ市場規模推移 ・アンロチニブのイギリス市場規模推移 ・アンロチニブのロシア市場規模推移 ・アンロチニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・アンロチニブの日本市場規模推移 ・アンロチニブの中国市場規模推移 ・アンロチニブの韓国市場規模推移 ・アンロチニブのインド市場規模推移 ・アンロチニブの東南アジア市場規模推移 ・アンロチニブの南米市場分析（ブラジル、アルゼンチン等） ・アンロチニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・アンロチニブの種類別分析/販売量、売上、市場シェア（8mgカプセル、10mgカプセル、12mgカプセル） ・アンロチニブの用途別分析/市場規模（NPO、政府、個人用、その他） ・アンロチニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・アンロチニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Anlotinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Anlotinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CHIA TAI TIANQING
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
8mg Capsules
10mg Capsules
12mg Capsules
Market Segment by Applications, can be divided into
Non-small Cell Lung Cancer
Ovarian Cancer
Soft Tissue Sarcoma
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anlotinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anlotinib, with price, sales, revenue and global market share of Anlotinib in 2017 and 2018.
Chapter 3, the Anlotinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anlotinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Anlotinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Anlotinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anlotinib Introduction
1.2 Market Analysis by Type
1.2.1 8mg Capsules
1.2.2 10mg Capsules
1.2.3 12mg Capsules
1.3 Market Analysis by Applications
1.3.1 Non-small Cell Lung Cancer
1.3.2 Ovarian Cancer
1.3.3 Soft Tissue Sarcoma
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CHIA TAI TIANQING
2.1.1 Business Overview
2.1.2 Anlotinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CHIA TAI TIANQING Anlotinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anlotinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Anlotinib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Anlotinib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Anlotinib Manufacturer Market Share in 2018
3.3.2 Top 6 Anlotinib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Anlotinib Market Analysis by Regions
4.1 Global Anlotinib Sales, Revenue and Market Share by Regions
4.1.1 Global Anlotinib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Anlotinib Revenue and Market Share by Regions (2014-2019)
4.2 North America Anlotinib Sales and Growth Rate (2014-2019)
4.3 Europe Anlotinib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Anlotinib Sales and Growth Rate (2014-2019)
4.5 South America Anlotinib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Anlotinib Sales and Growth Rate (2014-2019)
5 North America Anlotinib by Country
5.1 North America Anlotinib Sales, Revenue and Market Share by Country
5.1.1 North America Anlotinib Sales and Market Share by Country (2014-2019)
5.1.2 North America Anlotinib Revenue and Market Share by Country (2014-2019)
5.2 United States Anlotinib Sales and Growth Rate (2014-2019)
5.3 Canada Anlotinib Sales and Growth Rate (2014-2019)
5.4 Mexico Anlotinib Sales and Growth Rate (2014-2019)
6 Europe Anlotinib by Country
6.1 Europe Anlotinib Sales, Revenue and Market Share by Country
6.1.1 Europe Anlotinib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Anlotinib Revenue and Market Share by Country (2014-2019)
6.2 Germany Anlotinib Sales and Growth Rate (2014-2019)
6.3 UK Anlotinib Sales and Growth Rate (2014-2019)
6.4 France Anlotinib Sales and Growth Rate (2014-2019)
6.5 Russia Anlotinib Sales and Growth Rate (2014-2019)
6.6 Italy Anlotinib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Anlotinib by Country
7.1 Asia-Pacific Anlotinib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Anlotinib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Anlotinib Revenue and Market Share by Country (2014-2019)
7.2 China Anlotinib Sales and Growth Rate (2014-2019)
7.3 Japan Anlotinib Sales and Growth Rate (2014-2019)
7.4 Korea Anlotinib Sales and Growth Rate (2014-2019)
7.5 India Anlotinib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Anlotinib Sales and Growth Rate (2014-2019)
8 South America Anlotinib by Country
8.1 South America Anlotinib Sales, Revenue and Market Share by Country
8.1.1 South America Anlotinib Sales and Market Share by Country (2014-2019)
8.1.2 South America Anlotinib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Anlotinib Sales and Growth Rate (2014-2019)
8.3 Argentina Anlotinib Sales and Growth Rate (2014-2019)
8.4 Colombia Anlotinib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Anlotinib by Countries
9.1 Middle East and Africa Anlotinib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Anlotinib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Anlotinib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Anlotinib Sales and Growth Rate (2014-2019)
9.3 Turkey Anlotinib Sales and Growth Rate (2014-2019)
9.4 Egypt Anlotinib Sales and Growth Rate (2014-2019)
9.5 Nigeria Anlotinib Sales and Growth Rate (2014-2019)
9.6 South Africa Anlotinib Sales and Growth Rate (2014-2019)
10 Global Anlotinib Market Segment by Type
10.1 Global Anlotinib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Anlotinib Sales and Market Share by Type (2014-2019)
10.1.2 Global Anlotinib Revenue and Market Share by Type (2014-2019)
10.2 8mg Capsules Sales Growth and Price
10.2.1 Global 8mg Capsules Sales Growth (2014-2019)
10.2.2 Global 8mg Capsules Price (2014-2019)
10.3 10mg Capsules Sales Growth and Price
10.3.1 Global 10mg Capsules Sales Growth (2014-2019)
10.3.2 Global 10mg Capsules Price (2014-2019)
10.4 12mg Capsules Sales Growth and Price
10.4.1 Global 12mg Capsules Sales Growth (2014-2019)
10.4.2 Global 12mg Capsules Price (2014-2019)
11 Global Anlotinib Market Segment by Application
11.1 Global Anlotinib Sales Market Share by Application (2014-2019)
11.2 Non-small Cell Lung Cancer Sales Growth (2014-2019)
11.3 Ovarian Cancer Sales Growth (2014-2019)
11.4 Soft Tissue Sarcoma Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Anlotinib Market Forecast (2019-2024)
12.1 Global Anlotinib Sales, Revenue and Growth Rate (2019-2024)
12.2 Anlotinib Market Forecast by Regions (2019-2024)
12.2.1 North America Anlotinib Market Forecast (2019-2024)
12.2.2 Europe Anlotinib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Anlotinib Market Forecast (2019-2024)
12.2.4 South America Anlotinib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Anlotinib Market Forecast (2019-2024)
12.3 Anlotinib Market Forecast by Type (2019-2024)
12.3.1 Global Anlotinib Sales Forecast by Type (2019-2024)
12.3.2 Global Anlotinib Market Share Forecast by Type (2019-2024)
12.4 Anlotinib Market Forecast by Application (2019-2024)
12.4.1 Global Anlotinib Sales Forecast by Application (2019-2024)
12.4.2 Global Anlotinib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Anlotinib Picture
Table Product Specifications of Anlotinib
Figure Global Sales Market Share of Anlotinib by Types in 2018
Table Anlotinib Types for Major Manufacturers
Figure 8mg Capsules Picture
Figure 10mg Capsules Picture
Figure 12mg Capsules Picture
Figure Anlotinib Sales Market Share by Applications in 2018
Figure Non-small Cell Lung Cancer Picture
Figure Ovarian Cancer Picture
Figure Soft Tissue Sarcoma Picture
Figure Other Picture
Figure United States Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure France Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure China Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure India Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Anlotinib Revenue (Value) and Growth Rate (2014-2024)
Table CHIA TAI TIANQING Basic Information, Manufacturing Base and Competitors
Table CHIA TAI TIANQING Anlotinib Type and Applications
Table CHIA TAI TIANQING Anlotinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Anlotinib Sales by Manufacturer (2017-2018)
Figure Global Anlotinib Sales Market Share by Manufacturer in 2017
Figure Global Anlotinib Sales Market Share by Manufacturer in 2018
Table Global Anlotinib Revenue by Manufacturer (2017-2018)
Figure Global Anlotinib Revenue Market Share by Manufacturer in 2017
Figure Global Anlotinib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Anlotinib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Anlotinib Manufacturer (Revenue) Market Share in 2018
Figure Global Anlotinib Sales and Growth Rate (2014-2019)
Figure Global Anlotinib Revenue and Growth Rate (2014-2019)
Table Global Anlotinib Sales by Regions (2014-2019)
Table Global Anlotinib Sales Market Share by Regions (2014-2019)
Table Global Anlotinib Revenue by Regions (2014-2019)
Figure Global Anlotinib Revenue Market Share by Regions (2014-2019)
Figure Global Anlotinib Revenue Market Share by Regions in 2018
Figure North America Anlotinib Sales and Growth Rate (2014-2019)
Figure Europe Anlotinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Anlotinib Sales and Growth Rate (2014-2019)
Figure South America Anlotinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Anlotinib Sales and Growth Rate (2014-2019)
Figure North America Anlotinib Revenue and Growth Rate (2014-2019)
Table North America Anlotinib Sales by Countries (2014-2019)
Table North America Anlotinib Sales Market Share by Countries (2014-2019)
Figure North America Anlotinib Sales Market Share by Countries (2014-2019)
Figure North America Anlotinib Sales Market Share by Countries in 2018
Table North America Anlotinib Revenue by Countries (2014-2019)
Table North America Anlotinib Revenue Market Share by Countries (2014-2019)
Figure North America Anlotinib Revenue Market Share by Countries (2014-2019)
Figure North America Anlotinib Revenue Market Share by Countries in 2018
Figure United States Anlotinib Sales and Growth Rate (2014-2019)
Figure Canada Anlotinib Sales and Growth Rate (2014-2019)
Figure Mexico Anlotinib Sales and Growth Rate (2014-2019)
Figure Europe Anlotinib Revenue and Growth Rate (2014-2019)
Table Europe Anlotinib Sales by Countries (2014-2019)
Table Europe Anlotinib Sales Market Share by Countries (2014-2019)
Table Europe Anlotinib Revenue by Countries (2014-2019)
Figure Europe Anlotinib Revenue Market Share by Countries (2014-2019)
Figure Europe Anlotinib Revenue Market Share by Countries in 2018
Figure Germany Anlotinib Sales and Growth Rate (2014-2019)
Figure UK Anlotinib Sales and Growth Rate (2014-2019)
Figure France Anlotinib Sales and Growth Rate (2014-2019)
Figure Russia Anlotinib Sales and Growth Rate (2014-2019)
Figure Italy Anlotinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Anlotinib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Anlotinib Sales by Countries (2014-2019)
Table Asia-Pacific Anlotinib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Anlotinib Sales Market Share by Countries 2018
Table Asia-Pacific Anlotinib Revenue by Countries (2014-2019)
Figure Asia-Pacific Anlotinib Revenue Market Share by Countries 2018
Figure China Anlotinib Sales and Growth Rate (2014-2019)
Figure Japan Anlotinib Sales and Growth Rate (2014-2019)
Figure Korea Anlotinib Sales and Growth Rate (2014-2019)
Figure India Anlotinib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Anlotinib Sales and Growth Rate (2014-2019)
Figure South America Anlotinib Revenue and Growth Rate (2014-2019)
Table South America Anlotinib Sales by Countries (2014-2019)
Table South America Anlotinib Sales Market Share by Countries (2014-2019)
Figure South America Anlotinib Sales Market Share by Countries in 2018
Table South America Anlotinib Revenue by Countries (2014-2019)
Table South America Anlotinib Revenue Market Share by Countries (2014-2019)
Figure South America Anlotinib Revenue Market Share by Countries in 2018
Figure Brazil Anlotinib Sales and Growth Rate (2014-2019)
Figure Argentina Anlotinib Sales and Growth Rate (2014-2019)
Figure Colombia Anlotinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Anlotinib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Anlotinib Sales by Countries (2014-2019)
Table Middle East and Africa Anlotinib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Anlotinib Sales Market Share by Countries in 2018
Table Middle East and Africa Anlotinib Revenue by Countries (2014-2019)
Table Middle East and Africa Anlotinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anlotinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anlotinib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Anlotinib Sales and Growth Rate (2014-2019)
Figure UAE Anlotinib Sales and Growth Rate (2014-2019)
Figure Egypt Anlotinib Sales and Growth Rate (2014-2019)
Figure Nigeria Anlotinib Sales and Growth Rate (2014-2019)
Figure South Africa Anlotinib Sales and Growth Rate (2014-2019)
Table Global Anlotinib Sales by Type (2014-2019)
Table Global Anlotinib Sales Share by Type (2014-2019)
Table Global Anlotinib Revenue by Type (2014-2019)
Table Global Anlotinib Revenue Share by Type (2014-2019)
Figure Global 8mg Capsules Sales Growth (2014-2019)
Figure Global 8mg Capsules Price (2014-2019)
Figure Global 10mg Capsules Sales Growth (2014-2019)
Figure Global 10mg Capsules Price (2014-2019)
Figure Global 12mg Capsules Sales Growth (2014-2019)
Figure Global 12mg Capsules Price (2014-2019)
Table Global Anlotinib Sales by Application (2014-2019)
Table Global Anlotinib Sales Share by Application (2014-2019)
Figure Global Ovarian Cancer Sales Growth (2014-2019)
Figure Global Soft Tissue Sarcoma Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Anlotinib Sales, Revenue and Growth Rate (2019-2024)
Table Global Anlotinib Sales Forecast by Regions (2019-2024)
Table Global Anlotinib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Anlotinib Market Forecast (2019-2024)
Figure Europe Sales Anlotinib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Anlotinib Market Forecast (2019-2024)
Figure South America Sales Anlotinib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Anlotinib Market Forecast (2019-2024)
Table Global Anlotinib Sales Forecast by Type (2019-2024)
Table Global Anlotinib Market Share Forecast by Type (2019-2024)
Table Global Anlotinib Sales Forecast by Application (2019-2024)
Table Global Anlotinib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
非小細胞肺がん市場：世界及び中国の市場分析・予測（～2024年） Non-small Cell Lung Cancer Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Non-small Cell Lung Cancer industry with a focus on the Chinese market. The report provides key statistics on the market status of the Non-small Cell L…- 非小細胞肺癌治療薬市場：世界及び中国市場分析・予測（～2024年） Drugs for Non-small Cell Lung Cancer Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drugs for Non-small Cell Lung Cancer industry with a focus on the Chinese market. The report provides key statistics on the market status of …
- 世界のソフトカプセル充填機市場2019 The global Soft Capsules Filling Machines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report studies the global Soft Capsules Filling Machines market status and forecast, categorizes the global Soft Cap…
- ニラパリブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Niraparib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Niraparib in global market, e…
- ゼラチン系カプセルの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Gelatin Based Capsules is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Gelatin Based Capsules in …